首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Therapeutic effects of bee venom and its major component melittin on atopic dermatitis in vivo and in vitro
【2h】

Therapeutic effects of bee venom and its major component melittin on atopic dermatitis in vivo and in vitro

机译:蜂毒及其主要成分蜂毒肽对体内和体外特应性皮炎的治疗作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background and PurposeAtopic dermatitis (AD) is a multifactorial skin condition with complex interactions of innate and adaptive immune responses. There are several existing therapies for AD, including topical glucocorticosteroids, emollients, phototherapies, calcineurin inhibitors and immunosuppressants, such as cyclosporine A. Although these therapies reduce inflammation, they also cause serious side effects. Therefore, it is necessary to develop new therapeutic approaches for AD treatment without side effects. There are several studies on natural materials or toxins, such as herbs, ginseng extract and snake venom, for AD treatment. However, treatment of AD with bee venom and its major component, melittin has rarely been studied.
机译:背景与目的特应性皮炎(AD)是一种多因素皮肤病,其先天和适应性免疫反应之间相互作用复杂。现有几种用于AD的疗法,包括局部用糖皮质激素,润肤剂,光疗,钙调神经磷酸酶抑制剂和免疫抑制剂(例如环孢霉素A)。尽管这些疗法减轻了炎症,但它们也会引起严重的副作用。因此,有必要开发无副作用的AD治疗新的治疗方法。对天然物质或毒素(例如草药,人参提取物和蛇毒)进行AD治疗的研究很多。但是,很少研究用蜂毒及其主要成分蜂毒肽治疗AD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号